Register now for RT’s free webinar focusing on opportunities and challenges in home respiratory care, starting at 11am ET (8am PT) on Friday, November 21st.
RT Magazine’s annual Product Guide, which includes more than 60 of the newest respiratory care products from 50 leading manufacturers, is now available on our enhanced mobile application for tablets and smartphones.
You are thirty times more likely to come across the word vape than you were two years ago, and usage has more than doubled in the past year.
Medscape interviews a physician on pirfenidone and nintedanib, the two drugs approved by the FDA in October to treat idiopathic pulmonary fibrosis.
A literature study explored the effects of inhaled corticosteroids on incident pneumonia and mortality in patients with COPD.
Organic-Vaccines recently applied to the World Health Organization for compassionate use of the company’s MERS-CoV vaccine.
Arrowhead Research has filed an application with regulators to begin a Phase I trial of its alpha-1 antitrypsin deficiency (AAT) drug ARC-AAT in Australia.
Vanderbilt Heart & Vascular Institute now offers a specialized surgical approach – called pulmonary thromboendarterectomy – to treat chronic thromboembolic pulmonary hypertension (CTEPH).
Researchers say lipids leftover in the lungs are part of a process that causes immune cells to contribute to fibrotic lung disease.
The antibiotic azithromycin may reduce the risk of recurrent wheezing in infants hospitalized with respiratory syncytial virus (RSV).
Scientists have developed a procedure that restores function to muscles involved in the control of breathing, even when they have been paralyzed for more than a year.
On World COPD Day (November 19, 2014), the Forum of International Respiratory Societies (FIRS) is mobilizing its members to raise awareness of the disease and help prevent the risk factors that cause it.